GLP-1s May Prevent Rheumatic Disease From Developing A Harvard-led propensity-matched cohort study, also presented at ACR Convergence 2025 by Dr
Glenn Laboratories for the Biological Mechanisms of Aging at Harvard, of which Sinclair became the founding director
The effect size was moderate (standardised mean difference around 0.6), indicating that zinc helped reduce symptom severity
doi: 10.3390/biom13081170
The primary difference between the two lies in the method of delivery
They have been applied in various fields, including cancer therapy, gene, protein, and enzyme delivery, solubility enhancement, transdermal and ocular delivery, drug targeting, stimuli-responsive drug delivery, diagnostic purposes, globular protein mimics, and photodynamic therapy [197]